title: Are alternative donors really still "alternative?".
authors.affiliation: Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Kanakry
authors.affiliation: Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: luznile@jhmi.edu.
authors.forename: Leo
authors.initials: L
authors.lastname: Luznik
mesh_terms: D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000627:therapeutic use; D015870:Gene Expression; D006086:Graft vs Host Disease / Q000517:prevention & control; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D006239:Haplotypes; D019337:Hematologic Neoplasms / Q000235:genetics / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012008:Recurrence; D035781:Siblings; D016019:Survival Analysis; D014184:Transplantation, Homologous; D061349:Unrelated Donors
chemical_list: D006680:HLA Antigens; D007166:Immunosuppressive Agents; D016572:Cyclosporine
references.citation: J Clin Oncol. 2009 Apr 1;27(10):1644-52
references.pmid: 19224849
references.citation: Semin Oncol. 2012 Dec;39(6):683-93
references.pmid: 23206845
references.citation: Bone Marrow Transplant. 2002 Nov;30(10):681-6
references.pmid: 12420207
references.citation: Pediatr Rep. 2011 Jun 22;3 Suppl 2:e15
references.pmid: 22053277
references.citation: Curr Opin Immunol. 1999 Oct;11(5):521-6
references.pmid: 10508715
references.citation: Blood. 2011 Jul 14;118(2):282-8
references.pmid: 21527516
references.citation: Blood. 2010 Sep 16;116(11):1839-48
references.pmid: 20538804
references.citation: Semin Oncol. 2012 Dec;39(6):643-52
references.pmid: 23206841
references.citation: Eur J Haematol. 2014 Sep;93(3):187-97
references.pmid: 24660868
references.citation: Blood. 2012 Apr 26;119(17):3908-16
references.pmid: 22327226
references.citation: Blood. 2001 May 15;97(10):2962-71
references.pmid: 11342418
references.citation: Biol Blood Marrow Transplant. 2013 Sep;19(9):1355-60
references.pmid: 23791622
references.citation: Blood. 2010 Apr 22;115(16):3224-30
references.pmid: 20124511
references.citation: Bone Marrow Transplant. 1994;14 Suppl 4:S34-8
references.pmid: 7728122
references.citation: J Clin Oncol. 2014 Nov 1;32(31):3497-505
references.pmid: 25267759
references.citation: J Clin Oncol. 2013 Apr 1;31(10):1310-6
references.pmid: 23423745
references.citation: Hum Immunol. 1990 Oct;29(2):79-91
references.pmid: 2249952
references.citation: Blood. 2010 Nov 25;116(22):4693-9
references.pmid: 20686119
references.citation: Haematologica. 2014 Feb;99(2):322-8
references.pmid: 24056817
references.citation: Biol Blood Marrow Transplant. 2014 Oct;20(10):1573-9
references.pmid: 24910379
references.citation: J Clin Oncol. 1997 May;15(5):1767-77
references.pmid: 9164184
references.citation: Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50
references.pmid: 18489989
references.citation: Blood. 2009 Mar 26;113(13):3110-8
references.pmid: 19059878
references.citation: Biol Blood Marrow Transplant. 2008 Nov;14(11):1279-87
references.pmid: 18940683
references.citation: J Clin Oncol. 2006 Dec 20;24(36):5695-702
references.pmid: 17116940
references.citation: Semin Oncol. 2012 Dec;39(6):653-63
references.pmid: 23206842
references.citation: Lancet. 2007 Jun 9;369(9577):1947-54
references.pmid: 17560447
references.citation: Haematologica. 2014 Feb;99(2):370-7
references.pmid: 23935024